Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats

Brain Research

Volumn 1301, Issue , 2009, Pages 52-60

  Reeta, K H ^a   Mehla, Jogender ^a   Gupta, Yogendra Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cognitive impairment; Curcumin; Oxidative stress; Phenytoin

Indexed keywords

CURCUMIN; GLUTATHIONE; MALONALDEHYDE; PHENYTOIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN PROTECTION; COGNITIVE DEFECT; CONTROLLED STUDY; LEARNING; LEARNING DISORDER; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; COGNITION; COGNITION DISORDERS; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; GLUTATHIONE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MAZE LEARNING; OXIDATIVE STRESS; PHENYTOIN; RATS; RATS, WISTAR; RETENTION (PSYCHOLOGY);

RATTUS; RATTUS NORVEGICUS;

EID: 71849093750     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.09.027     Document Type: Article

References (63)

1. Aggarwal B.B., and Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 41 (2009) 40-59
2. Aggarwal B.B., and Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci. 30 (2009) 85-94
3. Ahmed T., and Gilani A.H. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease. Pharmacol. Biochem. Behav. 91 (2009) 554-559
4. Bhattacharya S., Mandal D., Sen G.S., Pal S., Banerjee S., Lahiry L., Finke J.H., Tannenbaum C.S., Das T., and Sa G. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. Cancer Res. 67 (2007) 362-370
5. Bhuller Y., Jeng W., and Wells P.G. Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice. Toxicol. Sci. 93 (2006) 146-155
6. Blatt S.L., and Takahashi R.N. Memory-impairing effects of local anesthetics in an elevated plus-maze test in mice. Braz. J. Med. Biol. Res. 31 (1998) 555-559
7. Brodie M.J., and Dichter M.A. Antiepileptic drugs. N. Engl. J. Med. 334 (1996) 168-175
8. Brouk B. Plants consumed by man (1975), Academic Press, New York 331
9. Da Cunha I.C., José R.F., Orlandi Pereira L., Pimenta J.A., Oliveira de Souza I.A., Reiser R., Moreno Jr. H., Marino Neto J., Paschoalini M.A., and Faria M.S. The role of nitric oxide in the emotional learning of rats in the plus-maze. Physiol. Behav. 84 (2005) 351-358
10. Dairam A., Limson J.L., Watkins G.M., Antunes E., and Daya S. Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats. J. Agric. Food. Chem. 55 (2007) 1039-1044
11. Devinsky O. Patients with refractory seizures. N. Engl. J. Med. 340 (1999) 1565-1570
12. Duncan J.S. Principles of treatment of patients with chronic active epilepsy. In: Shorvon S.D., Dreifuss F., Fish D., and Thomas D. (Eds). The treatment of epilepsy (1996), Blackwell Science, London 177-190
13. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82 (1959) 70-77
14. Fukui K., Omoi N.O., Hayasaka T., Shinnkai T., Suzuki S., Abe K., and Urano S. Cognitive impairment of rats caused by oxidative stress and aging and its prevention by vitamin E. Ann. N. Y. Acad. Sci. 959 (2002) 275-284
15. Gannaway D.J., and Mawer G.E. Serum phenytoin concentration and clinical response in patients with epilepsy. Br. J. Clin. Pharmacol. 12 (1981) 833-839
16. Garcia-Alloza M., Borrelli L.A., Rozkalne A., Hyman B.T., and Bacskai B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 102 (2007) 1095-1104
17. Hernandez R., Pernandez Mde.L., Miranda G., and Suastegin R. Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study. Rev. Invest. Clin. 57 (2005) 522-531
18. Isik A.T., Celik T., Ulusoy G., Ongoru O., Elibol B., Doruk H., Bozoglu E., Kayir H., Mas M.R., and Akman S. Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model. Age 31 (2009) 39-49
19. Itoh J., Nabeshima T., and Kameyama T. Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology (Berl.) 101 (1990) 27-33
20. Jefremov V., Zilmer M., Zilmer K., Bogdanovic N., and Karelson E. Antioxidative effects of plant polyphenols: from protection of G protein signaling to prevention of age-related pathologies. Ann. N. Y. Acad. Sci. 1095 (2007) 449-457
21. Jokeit H., Kramer G., and Ebner A. Do antiepileptic drugs accelerate forgetting. Epilepsy Behav. 6 (2005) 430-432
22. Keller J.N., Schmitt F.A., Scheff S.W., Ding Q., Chen Q., Butterfield D.A., and Markesbery W.R. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64 (2005) 1152-1156
23. Kumar A., Seghal N., Naidu P.S., Padi S.S., and Goyal R. Colchicines-induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type. Pharmacol. Rep. 59 (2007) 274-283
24. Kumar P., Padi S.S., Naidu P.S., and Kumar A. Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity. Methods Find Exp. Clin. Pharmacol. 29 (2007) 19-25
25. Leppik I.E., and Epilepsy foundation of America. Choosing an antiepileptic. Selecting drugs for older patients with epilepsy. Geriatrics 60 (2005) 42-47
26. Liu C.S., Wu H.M., Kao S.H., and Wei Y.H. Phenytoin-mediated oxidative stress in serum of female epileptics: a possible pathogenesis in the fetal hydantoin syndrome. Hum. Exp. Toxicol. 16 (1997) 177-181
27. Löscher W. The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy. Epilepsia 48 (2007) 1245-1258
28. Mahle C., and Dasgupta A. Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin. Life Sci. 61 (1997) 437-443
29. Martins de Lima M.N., Presti-Torres J., Dornelles A., Bromberg E., and Schr der N. Differential effects of low and high doses of topiramate on consolidation and retrieval of novel object recognition memory in rats. Epilepsy Behav. 10 (2007) 32-37
30. Mattson R.H., Cramer J.A., and Collins J.F. Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group. Neurology 47 (1996) 68-76
31. Mc Namara J.O. Pharmacotherapy of the epilepsies. In: Bruton L.L., Lazo J.S., and Parker K.J. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th edition (2006), Mc Graw-Hill, New York 501-525
32. Meador K.J., Loring D.W., Allen M.E., Zamrini E.Y., Moore E.E., Abney O.L., and King D.W. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 41 (1991) 1537-1540
33. Meador K.J., Loring D.W., Abney O.L., Allen M.E., Moore E.E., Zamrini E.Y., and King D.W. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 34 (1993) 153-157
34. Meador K.J., Loring D.W., Moore E.E., Thompson W.O., Nichols M.E., Oberzan R.E., Durkin M.W., Gallagher B.B., and King D.W. Comparative cognitive effects of phenobarbital, phenytoin and valproate in healthy adults. Neurology 45 (1995) 1494-1499
35. Naidech A.M., Kreiter K.T., Janjua N., Ostapkovich N., Parra A., Commichau C., Connolly E.S., Mayer S.A., and Fitzsimmons B.F. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid haemorrhage. Stroke 36 (2005) 583-587
36. Nakahara N., Iga Y., Mizobe F., and Kawanishi G. Effects of intracerebroventricular injection of AF64A on learning behaviors in rats. Jpn. J. Pharmacol. 48 1 (1988) 121-130
37. Navarová J., Ujházy E., Dubovický M., and Mach M. Phenytoin induced oxidative stress in pre- and postnatal rat development-effect of vitamin E on selective biochemical variables. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 149 (2005) 325-328
38. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
39. Ono H., Sakamoto A., and Sakura N. Plasma total glutathione concentrations in epileptic patients taking anticonvulsants. Clin. Chim. Acta 298 (2000) 135-143
40. Pan R., Qiu S., Lu D.X., and Dong J. Curcumin improves learning and memory ability and its neuroprotective mechanism in mice. Chin. Med. J. (Engl). 121 (2008) 832-839
41. Parnas J., Gram L., and Flachs H. Psychopharmacological aspects of antiepileptic treatment. Prog. Neurobiol. 15 (1980) 119-138
42. Picker M., and Poling A. Effects of anticonvulsants on learning: performance of pigeons under a repeated acquisition procedure when exposed to phenobarbital, clonazepam, valproic acid, ethosuximide and phenytoin. J. Pharmacol. Exp. Ther. 230 (1984) 307-316
43. Poling A., Blakely E., White W., and Picker M. Chronic effects of clonazepam, phenytoin, ethosuximide and valproic acid on learning in pigeons as assayed by a repeated acquisition procedure. Pharmacol. Biochem. Behav. 24 (1986) 1583-1586
44. Shahid M., Pillai K.K., and Vohora D. Reversal of phenytoin-induced impairment of spontaneous alternation by piracetam in mice: involvement of cholinergic system. Indian J. Pharmacol. 36 (2004) 20-24
45. Shannon H.E., and Love P.L. Effects of antiepileptic drugs on attention as assessed by a five choice strial reaction time task in rats. Epilepsy Behav. 7 (2005) 620-628
46. Shannon H.E., and Love P.L. Effects of antiepileptic drugs on learning as assessed by a repeated acquisition of response sequences task in rats. Epilepsy Behav. 10 (2007) 16-25
47. Sharma M., and Gupta Y.K. Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats. Pharmacol. Biochem. Behav. 70 (2001) 325-331
48. Sharma A.C., and Kulkarni S.K. Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 16 (1992) 117-125
49. Sharma R.A., Gescher A.J., and Steward W.P. Curcumin: the story so far. Eur. J. Cancer 41 (2005) 1955-1968
50. + ATPase and protein kinase C in adult and old rat brain regions. Biogerontology 10 (2009) 489-502
51. Shin H.J., Lee J.Y., Son E., Lee D.H., Kim H.J., Kang S.S., Cho G.J., Choi W.S., and Roh G.S. Curcumin attenuates the kainic acid-induced hippocampal cell death in the mice. Neurosci. Lett. 416 (2007) 49-54
52. Sonkusare S., Srinivasan K., Kaul C., and Ramarao P. Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci. 77 (2005) 1-14
53. Sudha S., Lakshmana M.K., and Pradhan N. Chronic phenytoin induced impairment of learning and memory with associated changes in brain acetylcholine esterase activity and monoamine levels. Pharmacol. Biochem. Behav. 52 (1995) 119-124
54. Tayyem R.F., Heath D.D., Al-Delaimy W.K., and Rock C.L. Curcumin content of turmeric and curry powders. Nutr. Cancer 55 (2006) 126-131
55. Thiyagarajan M., and Sharma S.S. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 74 (2004) 969-985
56. Thompson D.M. Repeated acquisition as a behavioral base line for studying drug effects. J. Pharmacol. Exp. Ther. 184 (1973) 506-514
57. Thompson P.J., and Duncan J.S. Cognitive decline in severe intractable epilepsy. Epilepsia 46 (2005) 1780-1787
58. Thompson P.J., and Trimble M.R. Anticonvulsant serum levels relationship to impairments of cognitive functioning. J. Neurol. Neurosurg. Psychiatry 46 (1983) 227-233
59. Tomson T., Dahl M.L., and Kimland E. Therapeutic monitoring of antiepileptic drugs for epilepsy. Cochrane Database Syst. Rev. 24 (2007) CD002216
60. Weintraub D., Buchsbaum R., Resor S.R., and Hirsch L.J. Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 10 (2007) 105-110
61. Winn L.M., Kim P.M., and Nickoloff J.A. Oxidative stress-induced homologous recombination as a novel mechanism for phenytoin-initiated toxicity. J. Pharmacol. Exp. Ther. 306 (2003) 523-537
62. Wu A., Ying Z., and Gomez-Pinilla F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp. Neurol. 197 (2006) 309-317
63. Zhao J., Zhao Y., Zheng W., Lu Y., Feng G., and Yu S. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res. 1229 (2008) 224-232